94 related articles for article (PubMed ID: 14599679)
1. Development and validation of a real-time PCR assay for the detection and quantitation of p53 recombinant adenovirus in clinical samples from patients treated with Ad5CMV-p53 (INGN 201).
Saulnier P; Vidaud M; Gautier E; Motté N; Bellet D; Escudier B; Wilson D; Yver A
J Virol Methods; 2003 Dec; 114(1):55-64. PubMed ID: 14599679
[TBL] [Abstract][Full Text] [Related]
2. Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with advanced cancer.
Tolcher AW; Hao D; de Bono J; Miller A; Patnaik A; Hammond LA; Smetzer L; Van Wart Hood J; Merritt J; Rowinsky EK; Takimoto C; Von Hoff D; Eckhardt SG
J Clin Oncol; 2006 May; 24(13):2052-8. PubMed ID: 16648505
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
Li JH; Li P; Klamut H; Liu FF
Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
[TBL] [Abstract][Full Text] [Related]
4. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
5. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
[TBL] [Abstract][Full Text] [Related]
6. Safety evaluation of Ad5CMV-p53 in vitro and in vivo.
Zhang WW; Alemany R; Wang J; Koch PE; Ordonez NG; Roth JA
Hum Gene Ther; 1995 Feb; 6(2):155-64. PubMed ID: 7734516
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53.
Wang J; Bucana CD; Roth JA; Zhang WW
Cancer Gene Ther; 1995 Mar; 2(1):9-17. PubMed ID: 7621257
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
[TBL] [Abstract][Full Text] [Related]
9. Additional gene therapy with Ad5CMV-p53 enhanced the efficacy of radiotherapy in human prostate cancer cells.
Sasaki R; Shirakawa T; Zhang ZJ; Tamekane A; Matsumoto A; Sugimura K; Matsuo M; Kamidono S; Gotoh A
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1336-45. PubMed ID: 11728695
[TBL] [Abstract][Full Text] [Related]
10. In vitro growth suppression by adenoviral transduction of p21 and p16 in squamous cell carcinoma of the head and neck: a research model for combination gene therapy.
Mobley SR; Liu TJ; Hudson JM; Clayman GL
Arch Otolaryngol Head Neck Surg; 1998 Jan; 124(1):88-92. PubMed ID: 9440786
[TBL] [Abstract][Full Text] [Related]
11. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21 WAF1/CIP1 and p16CDKN4) in human prostate cancers.
Gotoh A; Kao C; Ko SC; Hamada K; Liu TJ; Chung LW
J Urol; 1997 Aug; 158(2):636-41. PubMed ID: 9224383
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).
Clayman GL; Liu TJ; Overholt SM; Mobley SR; Wang M; Janot F; Goepfert H
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):489-93. PubMed ID: 8615965
[TBL] [Abstract][Full Text] [Related]
14. Preclinical study of adenoviral p53 gene therapy for esophageal cancer.
Shimada H; Shimizu T; Ochiai T; Liu TL; Sashiyama H; Nakamura A; Matsubara H; Gunji Y; Kobayashi S; Tagawa M; Sakiyama S; Hiwasa T
Surg Today; 2001; 31(7):597-604. PubMed ID: 11495154
[TBL] [Abstract][Full Text] [Related]
15. Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA.
Leutenegger CM; Higgins J; Matthews TB; Tarantal AF; Luciw PA; Pedersen NC; North TW
AIDS Res Hum Retroviruses; 2001 Feb; 17(3):243-51. PubMed ID: 11177407
[TBL] [Abstract][Full Text] [Related]
16. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
Pumannova M; Roubalova K; Vitek A; Sajdova J
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
18. Rapid and quantitative detection of human adenovirus DNA by real-time PCR.
Heim A; Ebnet C; Harste G; Pring-Akerblom P
J Med Virol; 2003 Jun; 70(2):228-39. PubMed ID: 12696109
[TBL] [Abstract][Full Text] [Related]
19. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma.
Li JH; Lax SA; Kim J; Klamut H; Liu FF
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):607-16. PubMed ID: 10078646
[TBL] [Abstract][Full Text] [Related]
20. [Detection of human adenoviruses with real-time PCR assay using TaqMan fluorescent probes].
Rola A; Przybylski M; Dzieciatkowski T; Turowska A; Łuczak M
Med Dosw Mikrobiol; 2007; 59(4):371-7. PubMed ID: 18416129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
